Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
50,481,729
-
Share change
-
-1,916,736
-
Total reported value
-
$6,541,552,799
-
Put/Call ratio
-
98%
-
Price per share
-
$129.49
-
Number of holders
-
328
-
Value change
-
-$247,055,871
-
Number of buys
-
128
-
Number of sells
-
180
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2014
As of 31 Dec 2014,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
328 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,481,729 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, SCOPIA CAPITAL MANAGEMENT LP, LSV ASSET MANAGEMENT, BlackRock Fund Advisors, ACADIAN ASSET MANAGEMENT LLC, BlackRock Advisors LLC, AJO, LP, DEUTSCHE BANK AG\, and BlackRock Institutional Trust Company, N.A..
This page lists
328
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.